store at low temperature
store at -80°C
Tildrakizumab (SCH 900222) is a potent humanized monoclonal antibody against IL-23 (p19 subunit). Tildrakizumab targets single-stranded IL-23 with a Kd value of 136 pM. Tildrakizumab can be used to study psoriasis and psoriasis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 328.00 | |
5 mg | In stock | $ 863.00 | |
10 mg | In stock | $ 1,380.00 |
Description | Tildrakizumab (SCH 900222) is a potent humanized monoclonal antibody against IL-23 (p19 subunit). Tildrakizumab targets single-stranded IL-23 with a Kd value of 136 pM. Tildrakizumab can be used to study psoriasis and psoriasis. |
Targets&IC50 | HeLa cells:23 pM |
In vitro | Tildrakizumab inhibits IL-23-induced STAT3 signaling in HeLa cells expressing human IL-23Rα and IL-12Rβ1 receptors, with an IC50 of 23 pM[2]. Tildrakizumab reduces the affinity of IL-23 for IL-23Rα through negative allosteric modulation[2]. |
In vivo | Tildrakizumab (100 mg/kg, subcutaneous injection, every two weeks, up to 9 months) demonstrates good tolerability in cynomolgus monkeys (toxicity study)[3]. |
Synonyms | MK 3222, SCH 900222 |
Molecular Weight | 144.4 (kDa) |
CAS No. | 1326244-10-3 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tildrakizumab 1326244-10-3 Immunology/Inflammation IL Receptor MK 3222 MK3222 SCH 900222 SCH900222 MK-3222 SCH-900222 inhibitor inhibit